贝纳利祖马布对严重喘炎症的影响:现实生活分析
Dina Visca1,2, Francesco Ardesi1, Martina Zappa1
1Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Therapeutic advances in respiratory disease
|December 17, 2024
概括
贝纳利祖马布有效治疗严重的酸性喘 (SEA),在一年内减少恶化并改善肺功能. 这种生物疗法还能使呼吸道炎症标志物正常化,这表明它对喘控制有广泛的影响.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的酸性喘 (SEA) 是一个具有挑战性的疾病.
- 单克隆抗体本拉利祖马布是一种SEA的治疗选择.
- 关于其对呼吸道炎症和肺功能影响的研究有限.
研究的目的:
- 评估本拉利祖马布在SEA患者呼吸道炎症治疗一年后的影响.
- 评估呼吸道炎症标志物与肺功能之间的相关性.
- 分析使用本拉利祖马布治疗的SEA患者的临床,功能和炎症结局.
主要方法:
- 意大利高等教育中心的回顾性观察研究.
- 包括22名SEA患者,他们接受了本拉利祖马布治疗1年.
- 在基线,6个月和12个月收集临床,功能和炎症数据.
主要成果:
- 严重恶化和全身类固醇使用的显著减少 (p < 0.0001).
- 控制喘的改善 (p < 0.0001),生活质量 (p = 0.017) 和肺功能 (FEV1,FEF25-75%).
- 唾液中氨基酸百分比的降低 (p < 0.005) 和与FEV1改善的相关性.
结论:
- 贝纳利祖马布是一种快速有效的SEA治疗方法,影响了多种结果.
- 诱导是监测喘的一个有价值的非侵入性工具.
- 及时转诊到专业中心可以缓解肺功能下降.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
Antiasthma Drugs: Leukotriene Modifiers
241
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
241
Antiasthma Drugs: β2-Adrenoceptor Agonists
232
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
232
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management
348
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
348
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349


